DUBLIN, Dec. 29, 2022 /PRNewswire/ -- The "Atrial Fibrillation Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
The global atrial fibrillation treatment market size reached US$ 6.3 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 12.4 Billion by 2027, exhibiting a CAGR of 11.95% during 2021-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor. It can also lead to the development of blood clots that may disrupt the blood flow to other organs. The main types of AFib include paroxysmal, persistent, long-term persistent, and permanent AFib that can be treated with medications and other interventions to adjust the heart's electrical impulses. The rising prevalence of cardiovascular diseases (CVDs) is one of the key factors driving the growth of the market. Such disorders are highly prevalent among the geriatric population and individuals suffering from other ailments, such as diabetes, hypertension and cardiovascular diseases (CVDs). This, along with the steadily increasing geriatric population across the globe, is providing a boost to the market growth. Furthermore, the increasing preference for minimally invasive (MI) surgical procedures is also creating a positive impact on the demand for miniaturized surgical devices, implant surgeries and remote nursing.
Additionally, various technological advancements, such as the development of catheter ablation devices to remove damaged heart tissues and innovative mapping and recording systems, is acting as another growth-inducing factor. Other factors, including improvements in the healthcare infrastructure and extensive research and development (R&D) activities in the field of medical sciences, are projected to drive the market further.
Key Questions Answered in This Report:
How has the global atrial fibrillation treatment market performed so far and how will it perform in the coming years? What are the key regional markets?
What is the breakup of the market based on the disorder type?
What is the breakup of the market based on the treatment type?
What is the breakup of the market based on the end-user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global atrial fibrillation treatment market and who are the key players? What is the degree of competition in the industry?
6 Market Breakup by Disorder Type
7 Market Breakup by Treatment Type
7.1.2 Surgical Procedures
7.1.2.2 Catheter Ablation
7.1.3 Non-Surgical Devices
7.1.3.1 Electric Cardioversion
7.1.3.2 Diagnostic Catheters
7.1.3.3 Mapping and Recording Systems
7.1.3.6 Left Atrial Appendage and Closure Devices
7.1.3.7 Intracardiac Echocardiography (ICE) Systems
8 Market Breakup by End-User
8.3 Ambulatory Surgical Centers
9 Market Breakup by Region
12 Porters Five Forces Analysis
13.3 Profiles of Key Players
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.8 Siemens Healthineers
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
For more information about this report visit https://www.researchandmarkets.com/r/5q7ajm
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets